Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

United States Combination Vaccine Market Report 2017

  • QYR2309131
  • 96 Pages
  • December 2017
  • Pharmaceuticals
Download Sample    Get Discount   
 
In this report, the United States Combination Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

The West

Southwest

The Middle Atlantic

New England

The South

The Midwest

with sales (volume), revenue (value), market share and growth rate of Combination Vaccine in these regions, from 2012 to 2022 (forecast).

United States Combination Vaccine market competition by top manufacturers/players, with Combination Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

GSK

Sanofi

Merck

Merial

Santa Cruz Animal Health

Ceva

...

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

By Antigen

Double Antigen

Multiple Antigen

By Type

People

Veterinary

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

Medical Care

Livestock

Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Combination Vaccine Market Report 2017

1 Combination Vaccine Overview

1.1 Product Overview and Scope of Combination Vaccine

1.2 Classification of Combination Vaccine by Product Category

1.2.1 United States Combination Vaccine Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States Combination Vaccine Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 Double Antigen

1.2.4 Multiple Antigen

1.3 United States Combination Vaccine Market by Application/End Users

1.3.1 United States Combination Vaccine Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Medical Care

1.3.3 Livestock

1.3.4 Others

1.4 United States Combination Vaccine Market by Region

1.4.1 United States Combination Vaccine Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West Combination Vaccine Status and Prospect (2012-2022)

1.4.3 Southwest Combination Vaccine Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic Combination Vaccine Status and Prospect (2012-2022)

1.4.5 New England Combination Vaccine Status and Prospect (2012-2022)

1.4.6 The South Combination Vaccine Status and Prospect (2012-2022)

1.4.7 The Midwest Combination Vaccine Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of Combination Vaccine (2012-2022)

1.5.1 United States Combination Vaccine Sales and Growth Rate (2012-2022)

1.5.2 United States Combination Vaccine Revenue and Growth Rate (2012-2022)

2 United States Combination Vaccine Market Competition by Players/Suppliers

2.1 United States Combination Vaccine Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States Combination Vaccine Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States Combination Vaccine Average Price by Players/Suppliers (2012-2017)

2.4 United States Combination Vaccine Market Competitive Situation and Trends

2.4.1 United States Combination Vaccine Market Concentration Rate

2.4.2 United States Combination Vaccine Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Combination Vaccine Manufacturing Base Distribution, Sales Area, Product Type

3 United States Combination Vaccine Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States Combination Vaccine Sales and Market Share by Region (2012-2017)

3.2 United States Combination Vaccine Revenue and Market Share by Region (2012-2017)

3.3 United States Combination Vaccine Price by Region (2012-2017)

4 United States Combination Vaccine Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States Combination Vaccine Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States Combination Vaccine Revenue and Market Share by Type (2012-2017)

4.3 United States Combination Vaccine Price by Type (2012-2017)

4.4 United States Combination Vaccine Sales Growth Rate by Type (2012-2017)

5 United States Combination Vaccine Sales (Volume) by Application (2012-2017)

5.1 United States Combination Vaccine Sales and Market Share by Application (2012-2017)

5.2 United States Combination Vaccine Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Combination Vaccine Players/Suppliers Profiles and Sales Data

6.1 GSK

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Combination Vaccine Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 GSK Combination Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Sanofi

6.2.2 Combination Vaccine Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Sanofi Combination Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Merck

6.3.2 Combination Vaccine Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Merck Combination Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Merial

6.4.2 Combination Vaccine Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Merial Combination Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Santa Cruz Animal Health

6.5.2 Combination Vaccine Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Santa Cruz Animal Health Combination Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Ceva

6.6.2 Combination Vaccine Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Ceva Combination Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

...

7 Combination Vaccine Manufacturing Cost Analysis

7.1 Combination Vaccine Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Combination Vaccine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Combination Vaccine Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Combination Vaccine Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Combination Vaccine Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States Combination Vaccine Sales Volume, Revenue Forecast (2017-2022)

11.2 United States Combination Vaccine Sales Volume Forecast by Type (2017-2022)

11.3 United States Combination Vaccine Sales Volume Forecast by Application (2017-2022)

11.4 United States Combination Vaccine Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Combination Vaccine

Figure United States Combination Vaccine Market Size (K Pcs) by Type (2012-2022)

Figure United States Combination Vaccine Sales Volume Market Share by Type (Product Category) in 2016

Figure Double Antigen Product Picture

Figure Multiple Antigen Product Picture

Figure United States Combination Vaccine Market Size (K Pcs) by Application (2012-2022)

Figure United States Sales Market Share of Combination Vaccine by Application in 2016

Figure Medical Care Examples

Table Key Downstream Customer in Medical Care

Figure Livestock Examples

Table Key Downstream Customer in Livestock

Figure Others Examples

Table Key Downstream Customer in Others

Figure United States Combination Vaccine Market Size (Million USD) by Region (2012-2022)

Figure The West Combination Vaccine Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest Combination Vaccine Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic Combination Vaccine Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England Combination Vaccine Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US Combination Vaccine Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest Combination Vaccine Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Combination Vaccine Sales (K Pcs) and Growth Rate (2012-2022)

Figure United States Combination Vaccine Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Combination Vaccine Market Major Players Product Sales Volume (K Pcs) (2012-2017)

Table United States Combination Vaccine Sales (K Pcs) of Key Players/Suppliers (2012-2017)

Table United States Combination Vaccine Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States Combination Vaccine Sales Share by Players/Suppliers

Figure 2017 United States Combination Vaccine Sales Share by Players/Suppliers

Figure United States Combination Vaccine Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States Combination Vaccine Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States Combination Vaccine Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States Combination Vaccine Revenue Share by Players/Suppliers

Figure 2017 United States Combination Vaccine Revenue Share by Players/Suppliers

Table United States Market Combination Vaccine Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)

Figure United States Market Combination Vaccine Average Price (USD/Pcs) of Key Players/Suppliers in 2016

Figure United States Combination Vaccine Market Share of Top 3 Players/Suppliers

Figure United States Combination Vaccine Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Combination Vaccine Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Combination Vaccine Product Category

Table United States Combination Vaccine Sales (K Pcs) by Region (2012-2017)

Table United States Combination Vaccine Sales Share by Region (2012-2017)

Figure United States Combination Vaccine Sales Share by Region (2012-2017)

Figure United States Combination Vaccine Sales Market Share by Region in 2016

Table United States Combination Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States Combination Vaccine Revenue Share by Region (2012-2017)

Figure United States Combination Vaccine Revenue Market Share by Region (2012-2017)

Figure United States Combination Vaccine Revenue Market Share by Region in 2016

Table United States Combination Vaccine Price (USD/Pcs) by Region (2012-2017)

Table United States Combination Vaccine Sales (K Pcs) by Type (2012-2017)

Table United States Combination Vaccine Sales Share by Type (2012-2017)

Figure United States Combination Vaccine Sales Share by Type (2012-2017)

Figure United States Combination Vaccine Sales Market Share by Type in 2016

Table United States Combination Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States Combination Vaccine Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Combination Vaccine by Type (2012-2017)

Figure Revenue Market Share of Combination Vaccine by Type in 2016

Table United States Combination Vaccine Price (USD/Pcs) by Types (2012-2017)

Figure United States Combination Vaccine Sales Growth Rate by Type (2012-2017)

Table United States Combination Vaccine Sales (K Pcs) by Application (2012-2017)

Table United States Combination Vaccine Sales Market Share by Application (2012-2017)

Figure United States Combination Vaccine Sales Market Share by Application (2012-2017)

Figure United States Combination Vaccine Sales Market Share by Application in 2016

Table United States Combination Vaccine Sales Growth Rate by Application (2012-2017)

Figure United States Combination Vaccine Sales Growth Rate by Application (2012-2017)

Table GSK Basic Information List

Table GSK Combination Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure GSK Combination Vaccine Sales Growth Rate (2012-2017)

Figure GSK Combination Vaccine Sales Market Share in United States (2012-2017)

Figure GSK Combination Vaccine Revenue Market Share in United States (2012-2017)

Table Sanofi Basic Information List

Table Sanofi Combination Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Sanofi Combination Vaccine Sales Growth Rate (2012-2017)

Figure Sanofi Combination Vaccine Sales Market Share in United States (2012-2017)

Figure Sanofi Combination Vaccine Revenue Market Share in United States (2012-2017)

Table Merck Basic Information List

Table Merck Combination Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Merck Combination Vaccine Sales Growth Rate (2012-2017)

Figure Merck Combination Vaccine Sales Market Share in United States (2012-2017)

Figure Merck Combination Vaccine Revenue Market Share in United States (2012-2017)

Table Merial Basic Information List

Table Merial Combination Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Merial Combination Vaccine Sales Growth Rate (2012-2017)

Figure Merial Combination Vaccine Sales Market Share in United States (2012-2017)

Figure Merial Combination Vaccine Revenue Market Share in United States (2012-2017)

Table Santa Cruz Animal Health Basic Information List

Table Santa Cruz Animal Health Combination Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Santa Cruz Animal Health Combination Vaccine Sales Growth Rate (2012-2017)

Figure Santa Cruz Animal Health Combination Vaccine Sales Market Share in United States (2012-2017)

Figure Santa Cruz Animal Health Combination Vaccine Revenue Market Share in United States (2012-2017)

Table Ceva Basic Information List

Table Ceva Combination Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Ceva Combination Vaccine Sales Growth Rate (2012-2017)

Figure Ceva Combination Vaccine Sales Market Share in United States (2012-2017)

Figure Ceva Combination Vaccine Revenue Market Share in United States (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Combination Vaccine

Figure Manufacturing Process Analysis of Combination Vaccine

Figure Combination Vaccine Industrial Chain Analysis

Table Raw Materials Sources of Combination Vaccine Major Players/Suppliers in 2016

Table Major Buyers of Combination Vaccine

Table Distributors/Traders List

Figure United States Combination Vaccine Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)

Figure United States Combination Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States Combination Vaccine Price (USD/Pcs) Trend Forecast (2017-2022)

Table United States Combination Vaccine Sales Volume (K Pcs) Forecast by Type (2017-2022)

Figure United States Combination Vaccine Sales Volume (K Pcs) Forecast by Type (2017-2022)

Figure United States Combination Vaccine Sales Volume (K Pcs) Forecast by Type in 2022

Table United States Combination Vaccine Sales Volume (K Pcs) Forecast by Application (2017-2022)

Figure United States Combination Vaccine Sales Volume (K Pcs) Forecast by Application (2017-2022)

Figure United States Combination Vaccine Sales Volume (K Pcs) Forecast by Application in 2022

Table United States Combination Vaccine Sales Volume (K Pcs) Forecast by Region (2017-2022)

Table United States Combination Vaccine Sales Volume Share Forecast by Region (2017-2022)

Figure United States Combination Vaccine Sales Volume Share Forecast by Region (2017-2022)

Figure United States Combination Vaccine Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370